Researchers identified three obesity subtypes in new research. In one subtype, individuals have low GLP-1 and rapid gastric ...
EU pushes “technical zero” limits for hazardous pesticide residues, while simplifying rules for low-risk substances.
“Would you like your receipt?” It’s a question you’re likely to hear every time you pop into the grocery store or stop for a ...
Publication in this premier journal after rigorous peer review validates the VIRAGE study and supports the continued evaluation of VCN-01 in ...
In comments to the U.S. EPA, Beyond Pesticides condemned the agency for failing to protect public health and the environment ...
In Spain, only 56% of people with obesity recognise that they have the disease. The finding shows a gap between health ...
Experts tackled CAR T access, trial equity, and overtreatment in breast cancer at an AJMC Institute for Value-Based Medicine ...
Scientists warn that proposed rollbacks in EU pesticide regulations could have far-reaching effects, weakening international ...
It is said that one in nine Japanese women will develop breast cancer. The onset of the disease increases rapidly from the ...
Continuous biomarker monitoring and AI-powered wearables could help detect subtle physiological changes earlier, but clinical ...
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive results from a Phase 2b trial evaluating the safety and efficacy of ...
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results